Updated Feb 21, 2018

HIV patients sue CVS over pharmacy networks

CVS faces a new lawsuit over its pharmacy networks for HIV/AIDS patients. Photo: RJ Sangosti / The Denver Post via Getty Images

Several HIV/AIDS patients have sued CVS Health, alleging the pharmacy giant flouted federal and state insurance laws by forcing patients into two options: fill their prescriptions at CVS locations or through CVS' mail order, or face thousands of dollars in out-of-pocket costs.

The big picture: It's another lawsuit that raises questions about how people with Aetna health insurance, especially those with expensive chronic conditions, would be treated if CVS got approval to acquire Aetna for $69 billion.

The class-action lawsuit, filed anonymously by patients due to the sensitivity of their conditions, also goes after employers like Amtrak that fund prescription drug plans for their employees and chose to use CVS. The suit boils down to a few key allegations:

  • Patients with a CVS drug plan previously had gone to other local, in-network specialty pharmacies to pick up their HIV/AIDS medications.
  • Patients were shocked to find out their old pharmacy was out-of-network, and they were on the hook for their medications, which could easily cost more than $2,000 a month.
  • CVS changed its pharmacy benefits a few years ago by requiring HIV/AIDS patients to either pick their drugs up at a CVS store or get them delivered to their homes, the suit claims.
  • One plaintiff who is not home several days a week said he found his 90-day mail-ordered supply of drugs "baking in the afternoon sun."
  • Patients also weren't comfortable picking up their drugs because many CVS stores lack private areas to ask questions.
  • The plaintiffs said they also weren't able to opt out of CVS' options.

The major question: Other lawsuits have alleged that CVS uses anticompetitive muscle to force business partners to use certain vendors. Would Aetna customers with conditions like HIV be forced to use CVS and cut ties with their old pharmacies at the risk of paying lots of money for prescriptions out of their pockets?

CVS' response: "We have not been served with this complaint and have not had an opportunity to thoroughly review the allegations. However, (CVS') highest priority is assuring patient access to clinically appropriate drugs while managing overall health care costs for our clients. To that end, we offer our clients multiple clinical tools and pharmacy network options targeted at achieving both of these goals."

Go deeper

Q&A: Minimizing your coronavirus risk

Illustration: Aïda Amer/Axios

As the coronavirus continues to spread throughout the U.S., Axios is answering readers' questions about the pandemic — how it spreads, who's at risk, and what you can do to stay safe.

What's new: This week, we answer five questions on smokers' vulnerability, food safety, visiting older parents, hair cut needs, and rural vs. urban impact.

The other coronavirus test we need

Illustration: Sarah Grillo/Axios

Researchers are racing to develop tests that detect whether someone may have developed immunity to the coronavirus, which could help society return to normal faster.

Why it matters: These tests could help people know if they are able to go back to work, as well as aid researchers in tracking the scale and death rate of the disease — key data for current and future pandemic policies.

Go deeperArrow24 mins ago - Health

What the U.S. can learn from other countries in the coronavirus fight

Data: The Center for Systems Science and Engineering at Johns Hopkins; Note: Cases are shown on a logarithmic scale; Chart: Naema Ahmed/Axios

The countries that have most successfully fended off the novel coronavirus have mainly done it with a combination of new technology and old-school principles.

Why it matters: There's a lot the U.S. can learn from the way other countries have handled this global pandemic — although we may not be able to apply those lessons as quickly as we'd like.

Go deeperArrow28 mins ago - Health